LEGN Legend Biotech Corp

$35.56

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Legend Biotech Corp

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.

Website: https://www.legendbiotech.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1801198
Address
2101 COTTONTAIL LANE, SOMERSET, NJ, UNITED STATES
Valuation
Market Cap
$6.02B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
5.79
Performance
EPS
$-0.96
Dividend Yield
—
Profit Margin
-28.20%
ROE
-15.40%
Technicals
50D MA
$35.23
200D MA
$42.92
52W High
$60.87
52W Low
$29.27
Fundamentals
Shares Outstanding
184M
Target Price
$77.99
Beta
0.21

LEGN EPS Estimates vs Actual

● Estimated
● Actual

LEGN News & Sentiment

Aug 18, 2025 • Benzinga SOMEWHAT-BULLISH
OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer
ROCKVILLE, Md., Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the appointment of Shiniu Wei as Chief Financial Officer ( CFO ) .
Aug 18, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
SOMERSET, N.J., Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Legend Biotech Corporation ( NASDAQ: LEGN ) ( Legend Biotech ) , a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company's Chief Financial Officer, effective immediately.
Aug 12, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Company News for Aug 12, 2025
Companies In The News Are: MU, AAON, LEGN, FNV.
Aug 11, 2025 • Zacks Commentary NEUTRAL
Key Inflation Data in Focus
U.S. stock futures edged higher this morning after an impressive last week. Despite uncertainties about the impact of the Trump administration's tariff and trade policies, the tech-heavy Nasdaq Composite posted all-time highs for both closing and intraday basis on Friday.
Aug 11, 2025 • Zacks Commentary NEUTRAL
Pre-Markets in Green, Inflation Data, Retail Sales, Q2 Earnings This Week
U.S. stock futures edged higher this morning after an impressive last week.
Jul 28, 2025 • GlobeNewswire NEUTRAL
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
SOMERSET, N.J., July 28, 2025 ( GLOBE NEWSWIRE ) -- Legend Biotech Corporation ( NASDAQ: LEGN ) ( Legend Biotech ) , a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Monday, August 11, 2025, to review second-quarter 2025 results.
Sentiment Snapshot

Average Sentiment Score:

0.108
50 articles with scored sentiment

Overall Sentiment:

Neutral

LEGN Reported Earnings

Mar 10, 2025
Dec 31, 2024 (Pre market)
0.52 Surprise
  • Reported EPS: $0.14
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: 137.2%
Nov 12, 2024
Sep 30, 2024 (Pre market)
-0.26 Surprise
  • Reported EPS: $-0.68
  • Estimate: $-0.42
  • Whisper: —
  • Surprise %: -62.8%
Aug 09, 2024
Jun 30, 2024 (Pre market)
0.28 Surprise
  • Reported EPS: $-0.10
  • Estimate: $-0.38
  • Whisper: —
  • Surprise %: 73.7%
May 13, 2024
Mar 31, 2024 (Pre market)
0.18 Surprise
  • Reported EPS: $-0.16
  • Estimate: $-0.34
  • Whisper: —
  • Surprise %: 52.9%
Mar 11, 2024
Dec 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.80
  • Estimate: $-0.83
  • Whisper: —
  • Surprise %: 3.6%
Nov 20, 2023
Sep 30, 2023 (Pre market)
0.34 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.68
  • Whisper: —
  • Surprise %: 50.0%
Aug 15, 2023
Jun 30, 2023 (Pre market)
-0.54 Surprise
  • Reported EPS: $-1.14
  • Estimate: $-0.60
  • Whisper: —
  • Surprise %: -90.0%
May 18, 2023
Mar 31, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $-0.68
  • Estimate: $-0.78
  • Whisper: —
  • Surprise %: 12.8%
Mar 30, 2023
Dec 31, 2022 (Post market)
-0.18 Surprise
  • Reported EPS: $-0.62
  • Estimate: $-0.44
  • Whisper: —
  • Surprise %: -40.9%

Financials